Mail

Mail Worms As Therapy Re: Bob Grant’s article about worm therapy for autoimmune disease:1 A minireview by Hanada et al., (Biol. Chem, 391:1365-70, 2010) of the RANKL/RANK system involving T-cell membrane protein ligands and ligand targets in various tissues, including specific neural and astroglial terrains in the brain, may provide additional support to the findings that inflammatory responses could play a role in autism. Mel Winestock

Written byThe Scientist
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Re: Bob Grant’s article about worm therapy for autoimmune disease:1 A minireview by Hanada et al., (Biol. Chem, 391:1365-70, 2010) of the RANKL/RANK system involving T-cell membrane protein ligands and ligand targets in various tissues, including specific neural and astroglial terrains in the brain, may provide additional support to the findings that inflammatory responses could play a role in autism.

Mel Winestock
ABD Laboratories
Oceanside, CA
2 In South Africa, where the free market adoption of genetically modified (GM) maize has risen to about 80 percent of the total hectarage grown, and even more for cotton, the crops were adopted enthusiastically precisely because they gave better yields, benefitting both the farmer and the consumer. The cost of seed for commercial growers is less of a constraint to profit than the extent of loss. And here, no one is worrying about the spread of traits, because everyone is growing.

The folks ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies